Liver cancer, breast cancer, pancreatic cancer
Conditions
Interventions
Experimental group:CD8T cell transfusion
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1)Age = 18 years old; basic normal function of important organs such as heart, lung, liver, and kidney; ECOG score 1 cm); (4)Willing to participate in this clinical study, able to cooperate with researchers, and sign informed consent; (5)No other tumors in the digestive tract, and no occurrence of intestinal obstruction in the past six months; (6)No uncontrollable hypertension, diabetes, heart disease, thrombosis, or active infections.
Exclusion criteria
Exclusion criteria: (1)Patients whose lesions cannot be sampled for ex vivo primary cell culture; (2)no Lack of cancer components after pathological diagnosis; (3)Failure of primary cell isolation and culture; (4)Presence of active infectious diseases, including active pulmonary tuberculosis, known human immunodeficiency virus (HIV) infection; (5)Subjects deemed unsuitable for participation in this clinical study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Adverse event occurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ctDNA; | — |
Countries
China
Contacts
Public ContactBeicheng Sun
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed